AU2005267062C1 - Compositions and methods of use for MGD-CSF in disease treatment - Google Patents

Info

Publication number

AU2005267062C1

AU2005267062C1 AU2005267062A AU2005267062A AU2005267062C1 AU 2005267062 C1 AU2005267062 C1 AU 2005267062C1 AU 2005267062 A AU2005267062 A AU 2005267062A AU 2005267062 A AU2005267062 A AU 2005267062A AU 2005267062 C1 AU2005267062 C1 AU 2005267062C1

Authority

AU

Australia

Prior art keywords

polypeptide

cells

chosen

antibody

csf

Prior art date

2004-07-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 196
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 84
• 201000010099 disease Diseases 0.000 title claims abstract description 62
• 238000011282 treatment Methods 0.000 title claims abstract description 23
• 239000000203 mixture Substances 0.000 title claims description 91
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 378
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 368
• 229920001184 polypeptide Polymers 0.000 claims abstract description 360
• 210000004027 cell Anatomy 0.000 claims abstract description 181
• 239000012634 fragment Substances 0.000 claims abstract description 126
• 102000040430 polynucleotide Human genes 0.000 claims abstract description 63
• 108091033319 polynucleotide Proteins 0.000 claims abstract description 63
• 239000002157 polynucleotide Substances 0.000 claims abstract description 63
• 206010028980 Neoplasm Diseases 0.000 claims abstract description 50
• 210000004443 dendritic cell Anatomy 0.000 claims abstract description 37
• 210000001616 monocyte Anatomy 0.000 claims abstract description 32
• 201000011510 cancer Diseases 0.000 claims abstract description 24
• 208000023275 Autoimmune disease Diseases 0.000 claims abstract description 22
• 230000004927 fusion Effects 0.000 claims abstract description 21
• 210000003714 granulocyte Anatomy 0.000 claims abstract description 18
• 208000027866 inflammatory disease Diseases 0.000 claims abstract description 10
• 206010055690 Foetal death Diseases 0.000 claims abstract description 8
• 230000000306 recurrent effect Effects 0.000 claims abstract description 5
• 150000007523 nucleic acids Chemical class 0.000 claims description 92
• 102000039446 nucleic acids Human genes 0.000 claims description 77
• 108020004707 nucleic acids Proteins 0.000 claims description 77
• 239000002243 precursor Substances 0.000 claims description 63
• 229920001223 polyethylene glycol Polymers 0.000 claims description 52
• 229920000642 polymer Polymers 0.000 claims description 51
• 239000002202 Polyethylene glycol Substances 0.000 claims description 50
• 241000282414 Homo sapiens Species 0.000 claims description 44
• 239000002773 nucleotide Substances 0.000 claims description 42
• 125000003729 nucleotide group Chemical group 0.000 claims description 42
• 210000000822 natural killer cell Anatomy 0.000 claims description 37
• 150000001413 amino acids Chemical class 0.000 claims description 34
• 210000002865 immune cell Anatomy 0.000 claims description 24
• 230000028993 immune response Effects 0.000 claims description 24
• 230000001965 increasing effect Effects 0.000 claims description 22
• 230000000692 anti-sense effect Effects 0.000 claims description 20
• 230000004044 response Effects 0.000 claims description 16
• 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 15
• 108090000994 Catalytic RNA Proteins 0.000 claims description 13
• 102000053642 Catalytic RNA Human genes 0.000 claims description 13
• 208000015181 infectious disease Diseases 0.000 claims description 13
• 108091092562 ribozyme Proteins 0.000 claims description 13
• 210000004881 tumor cell Anatomy 0.000 claims description 13
• 229960005486 vaccine Drugs 0.000 claims description 13
• 108091030071 RNAI Proteins 0.000 claims description 12
• 210000001185 bone marrow Anatomy 0.000 claims description 12
• 230000009368 gene silencing by RNA Effects 0.000 claims description 12
• 230000002401 inhibitory effect Effects 0.000 claims description 12
• 210000002540 macrophage Anatomy 0.000 claims description 11
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 11
• 230000004936 stimulating effect Effects 0.000 claims description 11
• 210000004698 lymphocyte Anatomy 0.000 claims description 10
• 201000006417 multiple sclerosis Diseases 0.000 claims description 10
• 125000003277 amino group Chemical group 0.000 claims description 9
• 108091023037 Aptamer Proteins 0.000 claims description 8
• 238000002512 chemotherapy Methods 0.000 claims description 7
• 125000003827 glycol group Chemical group 0.000 claims description 7
• 230000003834 intracellular effect Effects 0.000 claims description 7
• 208000024827 Alzheimer disease Diseases 0.000 claims description 6
• 208000010125 myocardial infarction Diseases 0.000 claims description 6
• 230000001537 neural effect Effects 0.000 claims description 6
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 6
• 230000002265 prevention Effects 0.000 claims description 6
• 208000036142 Viral infection Diseases 0.000 claims description 5
• 230000009385 viral infection Effects 0.000 claims description 5
• 206010061218 Inflammation Diseases 0.000 claims description 4
• 201000004681 Psoriasis Diseases 0.000 claims description 4
• 208000006011 Stroke Diseases 0.000 claims description 4
• 230000002708 enhancing effect Effects 0.000 claims description 4
• 230000004054 inflammatory process Effects 0.000 claims description 4
• 238000011275 oncology therapy Methods 0.000 claims description 4
• 244000052769 pathogen Species 0.000 claims description 4
• 238000001959 radiotherapy Methods 0.000 claims description 4
• 241000792859 Enema Species 0.000 claims description 3
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
• 239000007920 enema Substances 0.000 claims description 3
• 201000008482 osteoarthritis Diseases 0.000 claims description 3
• 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 claims description 3
• 230000004614 tumor growth Effects 0.000 claims description 3
• 208000007788 Acute Liver Failure Diseases 0.000 claims description 2
• 208000035143 Bacterial infection Diseases 0.000 claims description 2
• 206010017533 Fungal infection Diseases 0.000 claims description 2
• 206010028470 Mycoplasma infections Diseases 0.000 claims description 2
• 208000031888 Mycoses Diseases 0.000 claims description 2
• 108010071390 Serum Albumin Proteins 0.000 claims description 2
• 102000007562 Serum Albumin Human genes 0.000 claims description 2
• 230000001093 anti-cancer Effects 0.000 claims description 2
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
• 229940095399 enema Drugs 0.000 claims description 2
• 244000000056 intracellular parasite Species 0.000 claims description 2
• 230000001717 pathogenic effect Effects 0.000 claims description 2
• 230000035935 pregnancy Effects 0.000 claims description 2
• 230000009467 reduction Effects 0.000 claims description 2
• 230000001629 suppression Effects 0.000 claims 2
• 102000013361 fetuin Human genes 0.000 claims 1
• 108060002885 fetuin Proteins 0.000 claims 1
• 239000013598 vector Substances 0.000 abstract description 82
• 208000035473 Communicable disease Diseases 0.000 abstract description 10
• 230000001363 autoimmune Effects 0.000 abstract description 8
• 108010071942 Colony-Stimulating Factors Proteins 0.000 abstract description 4
• 238000010188 recombinant method Methods 0.000 abstract description 3
• 102000007644 Colony-Stimulating Factors Human genes 0.000 abstract 1
• 108090000623 proteins and genes Proteins 0.000 description 243
• 102000004169 proteins and genes Human genes 0.000 description 179
• 235000018102 proteins Nutrition 0.000 description 175
• 230000000694 effects Effects 0.000 description 69
• 102000005962 receptors Human genes 0.000 description 55
• 108020003175 receptors Proteins 0.000 description 54
• 230000014509 gene expression Effects 0.000 description 50
• 235000001014 amino acid Nutrition 0.000 description 46
• 239000005557 antagonist Substances 0.000 description 46
• 125000003275 alpha amino acid group Chemical group 0.000 description 42
• 230000004069 differentiation Effects 0.000 description 42
• 239000003795 chemical substances by application Substances 0.000 description 39
• 108020004414 DNA Proteins 0.000 description 37
• 230000027455 binding Effects 0.000 description 37
• 238000009739 binding Methods 0.000 description 37
• 230000003248 secreting effect Effects 0.000 description 34
• 125000000539 amino acid group Chemical group 0.000 description 32
• 238000001727 in vivo Methods 0.000 description 26
• 230000001225 therapeutic effect Effects 0.000 description 26
• 230000000295 complement effect Effects 0.000 description 25
• 239000000427 antigen Substances 0.000 description 24
• 102000036639 antigens Human genes 0.000 description 24
• 108091007433 antigens Proteins 0.000 description 24
• 230000006870 function Effects 0.000 description 24
• 108020004999 messenger RNA Proteins 0.000 description 24
• 210000001519 tissue Anatomy 0.000 description 24
• 238000003556 assay Methods 0.000 description 22
• 238000006243 chemical reaction Methods 0.000 description 22
• 208000035475 disorder Diseases 0.000 description 22
• 230000035755 proliferation Effects 0.000 description 22
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 21
• 239000000556 agonist Substances 0.000 description 21
• 150000001875 compounds Chemical class 0.000 description 21
• 238000006467 substitution reaction Methods 0.000 description 21
• 230000001404 mediated effect Effects 0.000 description 20
• 108091028043 Nucleic acid sequence Proteins 0.000 description 19
• 102000037865 fusion proteins Human genes 0.000 description 19
• 108020001507 fusion proteins Proteins 0.000 description 19
• -1 host cells Substances 0.000 description 19
• 238000002360 preparation method Methods 0.000 description 19
• 210000000130 stem cell Anatomy 0.000 description 19
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 18
• 239000002299 complementary DNA Substances 0.000 description 18
• 230000035772 mutation Effects 0.000 description 18
• 238000000746 purification Methods 0.000 description 18
• 239000000126 substance Substances 0.000 description 18
• 230000004071 biological effect Effects 0.000 description 17
• 230000004663 cell proliferation Effects 0.000 description 17
• 238000012217 deletion Methods 0.000 description 17
• 230000037430 deletion Effects 0.000 description 17
• 239000003446 ligand Substances 0.000 description 17
• 239000000047 product Substances 0.000 description 17
• 210000000349 chromosome Anatomy 0.000 description 16
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 15
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 15
• 101000998132 Homo sapiens Interleukin-34 Proteins 0.000 description 15
• 238000004519 manufacturing process Methods 0.000 description 15
• 230000028327 secretion Effects 0.000 description 15
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 14
• 230000015572 biosynthetic process Effects 0.000 description 14
• 238000003752 polymerase chain reaction Methods 0.000 description 14
• 239000000523 sample Substances 0.000 description 14
• 102100033499 Interleukin-34 Human genes 0.000 description 13
• 239000012472 biological sample Substances 0.000 description 13
• 239000003636 conditioned culture medium Substances 0.000 description 13
• 230000001177 retroviral effect Effects 0.000 description 13
• 210000001744 T-lymphocyte Anatomy 0.000 description 12
• 230000006907 apoptotic process Effects 0.000 description 12
• 238000000338 in vitro Methods 0.000 description 12
• 230000006320 pegylation Effects 0.000 description 12
• 238000004393 prognosis Methods 0.000 description 12
• 101150064015 FAS gene Proteins 0.000 description 11
• 241000725303 Human immunodeficiency virus Species 0.000 description 11
• 108060003951 Immunoglobulin Proteins 0.000 description 11
• 241001465754 Metazoa Species 0.000 description 11
• 238000007792 addition Methods 0.000 description 11
• 238000004458 analytical method Methods 0.000 description 11
• 230000000890 antigenic effect Effects 0.000 description 11
• 239000003814 drug Substances 0.000 description 11
• 102000018358 immunoglobulin Human genes 0.000 description 11
• 210000004962 mammalian cell Anatomy 0.000 description 11
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• 108091034117 Oligonucleotide Proteins 0.000 description 10
• 108010076504 Protein Sorting Signals Proteins 0.000 description 10
• 239000003184 complementary RNA Substances 0.000 description 10
• 238000009396 hybridization Methods 0.000 description 10
• 230000001939 inductive effect Effects 0.000 description 10
• 230000008569 process Effects 0.000 description 10
• 239000007787 solid Substances 0.000 description 10
• 108020005544 Antisense RNA Proteins 0.000 description 9
• 241000701022 Cytomegalovirus Species 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 238000004113 cell culture Methods 0.000 description 9
• 230000002759 chromosomal effect Effects 0.000 description 9
• 238000001212 derivatisation Methods 0.000 description 9
• 239000003937 drug carrier Substances 0.000 description 9
• 238000009472 formulation Methods 0.000 description 9
• 230000002163 immunogen Effects 0.000 description 9
• 230000003993 interaction Effects 0.000 description 9
• 238000013507 mapping Methods 0.000 description 9
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 9
• 238000001890 transfection Methods 0.000 description 9
• 230000003612 virological effect Effects 0.000 description 9
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 8
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 8
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
• 102100040247 Tumor necrosis factor Human genes 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 210000001175 cerebrospinal fluid Anatomy 0.000 description 8
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 8
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
• 210000004185 liver Anatomy 0.000 description 8
• 239000003550 marker Substances 0.000 description 8
• 210000004379 membrane Anatomy 0.000 description 8
• 239000012528 membrane Substances 0.000 description 8
• 239000013600 plasmid vector Substances 0.000 description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 8
• 239000013615 primer Substances 0.000 description 8
• 210000002966 serum Anatomy 0.000 description 8
• 230000004083 survival effect Effects 0.000 description 8
• 208000011580 syndromic disease Diseases 0.000 description 8
• 239000003981 vehicle Substances 0.000 description 8
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 7
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
• 206010018364 Glomerulonephritis Diseases 0.000 description 7
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 7
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 7
• 241000699670 Mus sp. Species 0.000 description 7
• 102100038081 Signal transducer CD24 Human genes 0.000 description 7
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 7
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 7
• 230000001580 bacterial effect Effects 0.000 description 7
• 210000004369 blood Anatomy 0.000 description 7
• 239000008280 blood Substances 0.000 description 7
• 210000004899 c-terminal region Anatomy 0.000 description 7
• 238000003745 diagnosis Methods 0.000 description 7
• 231100000673 dose–response relationship Toxicity 0.000 description 7
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 7
• 210000001723 extracellular space Anatomy 0.000 description 7
• 201000006747 infectious mononucleosis Diseases 0.000 description 7
• 230000002757 inflammatory effect Effects 0.000 description 7
• 230000004048 modification Effects 0.000 description 7
• 238000012986 modification Methods 0.000 description 7
• 239000000546 pharmaceutical excipient Substances 0.000 description 7
• 230000001105 regulatory effect Effects 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 230000035897 transcription Effects 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• 238000013519 translation Methods 0.000 description 7
• 108020004491 Antisense DNA Proteins 0.000 description 6
• 201000009030 Carcinoma Diseases 0.000 description 6
• 108091026890 Coding region Proteins 0.000 description 6
• 206010009944 Colon cancer Diseases 0.000 description 6
• 102000003849 Cytochrome P450 Human genes 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• 208000008771 Lymphadenopathy Diseases 0.000 description 6
• 108700026244 Open Reading Frames Proteins 0.000 description 6
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 230000001154 acute effect Effects 0.000 description 6
• 239000003816 antisense DNA Substances 0.000 description 6
• 230000008827 biological function Effects 0.000 description 6
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• 230000001684 chronic effect Effects 0.000 description 6
• 230000001143 conditioned effect Effects 0.000 description 6
• 230000003247 decreasing effect Effects 0.000 description 6
• 239000005547 deoxyribonucleotide Substances 0.000 description 6
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 6
• 238000001514 detection method Methods 0.000 description 6
• 210000003494 hepatocyte Anatomy 0.000 description 6
• 238000003384 imaging method Methods 0.000 description 6
• 208000026278 immune system disease Diseases 0.000 description 6
• 208000018555 lymphatic system disease Diseases 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 6
• 239000002245 particle Substances 0.000 description 6
• 239000013612 plasmid Substances 0.000 description 6
• 229920001308 poly(aminoacid) Polymers 0.000 description 6
• 238000011084 recovery Methods 0.000 description 6
• 238000012216 screening Methods 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 229920003169 water-soluble polymer Polymers 0.000 description 6
• 208000023328 Basedow disease Diseases 0.000 description 5
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
• 208000024172 Cardiovascular disease Diseases 0.000 description 5
• 229920002307 Dextran Polymers 0.000 description 5
• 241000196324 Embryophyta Species 0.000 description 5
• 208000015023 Graves' disease Diseases 0.000 description 5
• 208000031886 HIV Infections Diseases 0.000 description 5
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 5
• 241000238631 Hexapoda Species 0.000 description 5
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 5
• 108010087870 Mannose-Binding Lectin Proteins 0.000 description 5
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 201000003793 Myelodysplastic syndrome Diseases 0.000 description 5
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
• 238000005917 acylation reaction Methods 0.000 description 5
• 150000001299 aldehydes Chemical class 0.000 description 5
• 102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 description 5
• 108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 description 5
• 230000004075 alteration Effects 0.000 description 5
• 230000003042 antagnostic effect Effects 0.000 description 5
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 5
• 238000001574 biopsy Methods 0.000 description 5
• 230000000903 blocking effect Effects 0.000 description 5
• 210000002791 cfu-m Anatomy 0.000 description 5
• 230000008859 change Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 230000000875 corresponding effect Effects 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 230000001419 dependent effect Effects 0.000 description 5
• 229960002086 dextran Drugs 0.000 description 5
• 210000003527 eukaryotic cell Anatomy 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 230000002068 genetic effect Effects 0.000 description 5
• 208000024908 graft versus host disease Diseases 0.000 description 5
• 230000001976 improved effect Effects 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 125000003588 lysine group Chemical class [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 5
• 102000035118 modified proteins Human genes 0.000 description 5
• 108091005573 modified proteins Proteins 0.000 description 5
• 239000013642 negative control Substances 0.000 description 5
• 210000000440 neutrophil Anatomy 0.000 description 5
• 239000013610 patient sample Substances 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 210000002381 plasma Anatomy 0.000 description 5
• 230000002062 proliferating effect Effects 0.000 description 5
• 238000011160 research Methods 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 239000000243 solution Substances 0.000 description 5
• 239000000829 suppository Substances 0.000 description 5
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
• 229930024421 Adenine Natural products 0.000 description 4
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 208000020084 Bone disease Diseases 0.000 description 4
• 206010006187 Breast cancer Diseases 0.000 description 4
• 208000031229 Cardiomyopathies Diseases 0.000 description 4
• 108010035532 Collagen Proteins 0.000 description 4
• 102000008186 Collagen Human genes 0.000 description 4
• 206010056370 Congestive cardiomyopathy Diseases 0.000 description 4
• 206010059866 Drug resistance Diseases 0.000 description 4
• 108010086121 Fetuin-B Proteins 0.000 description 4
• 102100028044 Fetuin-B Human genes 0.000 description 4
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
• 102000009112 Mannose-Binding Lectin Human genes 0.000 description 4
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 4
• 238000005481 NMR spectroscopy Methods 0.000 description 4
• 206010029113 Neovascularisation Diseases 0.000 description 4
• 102000015636 Oligopeptides Human genes 0.000 description 4
• 108010038807 Oligopeptides Proteins 0.000 description 4
• 108091006006 PEGylated Proteins Proteins 0.000 description 4
• 208000018737 Parkinson disease Diseases 0.000 description 4
• 102100024554 Tetranectin Human genes 0.000 description 4
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 4
• 102000006601 Thymidine Kinase Human genes 0.000 description 4
• 108020004440 Thymidine kinase Proteins 0.000 description 4
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 4
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
• 230000021736 acetylation Effects 0.000 description 4
• 238000006640 acetylation reaction Methods 0.000 description 4
• 229960000643 adenine Drugs 0.000 description 4
• 208000009956 adenocarcinoma Diseases 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 208000006673 asthma Diseases 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 210000001124 body fluid Anatomy 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 4
• 230000030833 cell death Effects 0.000 description 4
• 230000024245 cell differentiation Effects 0.000 description 4
• 238000004587 chromatography analysis Methods 0.000 description 4
• 238000010367 cloning Methods 0.000 description 4
• 229920001436 collagen Polymers 0.000 description 4
• 229920001577 copolymer Polymers 0.000 description 4
• 235000018417 cysteine Nutrition 0.000 description 4
• 229940104302 cytosine Drugs 0.000 description 4
• 230000006378 damage Effects 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 206010012601 diabetes mellitus Diseases 0.000 description 4
• 239000003085 diluting agent Substances 0.000 description 4
• 239000002552 dosage form Substances 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 238000005516 engineering process Methods 0.000 description 4
• 150000002148 esters Chemical class 0.000 description 4
• 230000028023 exocytosis Effects 0.000 description 4
• 239000012530 fluid Substances 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 239000003102 growth factor Substances 0.000 description 4
• 230000003394 haemopoietic effect Effects 0.000 description 4
• 208000006454 hepatitis Diseases 0.000 description 4
• 210000003917 human chromosome Anatomy 0.000 description 4
• 229940072221 immunoglobulins Drugs 0.000 description 4
• 208000032839 leukemia Diseases 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 239000002609 medium Substances 0.000 description 4
• 230000002025 microglial effect Effects 0.000 description 4
• 206010028417 myasthenia gravis Diseases 0.000 description 4
• 238000004806 packaging method and process Methods 0.000 description 4
• 208000005987 polymyositis Diseases 0.000 description 4
• 230000006337 proteolytic cleavage Effects 0.000 description 4
• 238000005932 reductive alkylation reaction Methods 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 230000000717 retained effect Effects 0.000 description 4
• 238000010839 reverse transcription Methods 0.000 description 4
• 210000004739 secretory vesicle Anatomy 0.000 description 4
• 230000019491 signal transduction Effects 0.000 description 4
• 150000003384 small molecules Chemical class 0.000 description 4
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 239000006228 supernatant Substances 0.000 description 4
• 108010013645 tetranectin Proteins 0.000 description 4
• 238000002560 therapeutic procedure Methods 0.000 description 4
• 125000003396 thiol group Chemical group [H]S* 0.000 description 4
• 238000002054 transplantation Methods 0.000 description 4
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 4
• 241000701161 unidentified adenovirus Species 0.000 description 4
• 208000030507 AIDS Diseases 0.000 description 3
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 3
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 3
• 208000009137 Behcet syndrome Diseases 0.000 description 3
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 102000014914 Carrier Proteins Human genes 0.000 description 3
• 108010076119 Caseins Proteins 0.000 description 3
• 102000011632 Caseins Human genes 0.000 description 3
• 229920002261 Corn starch Polymers 0.000 description 3
• 208000011231 Crohn disease Diseases 0.000 description 3
• 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 description 3
• 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 description 3
• 206010012689 Diabetic retinopathy Diseases 0.000 description 3
• 238000009007 Diagnostic Kit Methods 0.000 description 3
• 238000012286 ELISA Assay Methods 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• 108700024394 Exon Proteins 0.000 description 3
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
• 208000037357 HIV infectious disease Diseases 0.000 description 3
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 3
• 241000711549 Hepacivirus C Species 0.000 description 3
• 208000017604 Hodgkin disease Diseases 0.000 description 3
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 3
• 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 3
• 108090000144 Human Proteins Proteins 0.000 description 3
• 102000003839 Human Proteins Human genes 0.000 description 3
• 108091006905 Human Serum Albumin Proteins 0.000 description 3
• 102000008100 Human Serum Albumin Human genes 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 102000006992 Interferon-alpha Human genes 0.000 description 3
• 108010047761 Interferon-alpha Proteins 0.000 description 3
• 102000003816 Interleukin-13 Human genes 0.000 description 3
• 108090000176 Interleukin-13 Proteins 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 108010002386 Interleukin-3 Proteins 0.000 description 3
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 3
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 3
• 206010067125 Liver injury Diseases 0.000 description 3
• 108060001084 Luciferase Proteins 0.000 description 3
• 239000005089 Luciferase Substances 0.000 description 3
• 206010025323 Lymphomas Diseases 0.000 description 3
• 241000124008 Mammalia Species 0.000 description 3
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 3
• 238000000636 Northern blotting Methods 0.000 description 3
• 101710163270 Nuclease Proteins 0.000 description 3
• 241000283973 Oryctolagus cuniculus Species 0.000 description 3
• 208000001132 Osteoporosis Diseases 0.000 description 3
• 206010033128 Ovarian cancer Diseases 0.000 description 3
• 206010061535 Ovarian neoplasm Diseases 0.000 description 3
• 239000004372 Polyvinyl alcohol Substances 0.000 description 3
• 206010060862 Prostate cancer Diseases 0.000 description 3
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 3
• 102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 3
• 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 3
• 201000000582 Retinoblastoma Diseases 0.000 description 3
• 206010039491 Sarcoma Diseases 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108020004459 Small interfering RNA Proteins 0.000 description 3
• 230000033540 T cell apoptotic process Effects 0.000 description 3
• 208000024313 Testicular Neoplasms Diseases 0.000 description 3
• 206010052779 Transplant rejections Diseases 0.000 description 3
• 206010047115 Vasculitis Diseases 0.000 description 3
• 208000027418 Wounds and injury Diseases 0.000 description 3
• 230000002159 abnormal effect Effects 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 230000010933 acylation Effects 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 230000002776 aggregation Effects 0.000 description 3
• 238000004220 aggregation Methods 0.000 description 3
• 150000001408 amides Chemical group 0.000 description 3
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 3
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
• 239000010839 body fluid Substances 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• 239000001506 calcium phosphate Substances 0.000 description 3
• 229910000389 calcium phosphate Inorganic materials 0.000 description 3
• 235000011010 calcium phosphates Nutrition 0.000 description 3
• 239000001768 carboxy methyl cellulose Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 210000003169 central nervous system Anatomy 0.000 description 3
• 206010008118 cerebral infarction Diseases 0.000 description 3
• 208000026106 cerebrovascular disease Diseases 0.000 description 3
• 238000007385 chemical modification Methods 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 239000008120 corn starch Substances 0.000 description 3
• 230000002596 correlated effect Effects 0.000 description 3
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 3
• 230000003013 cytotoxicity Effects 0.000 description 3
• 231100000135 cytotoxicity Toxicity 0.000 description 3
• 230000034994 death Effects 0.000 description 3
• 230000007547 defect Effects 0.000 description 3
• 230000007812 deficiency Effects 0.000 description 3
• 201000011304 dilated cardiomyopathy 1A Diseases 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 238000002509 fluorescent in situ hybridization Methods 0.000 description 3
• 238000001502 gel electrophoresis Methods 0.000 description 3
• 230000013595 glycosylation Effects 0.000 description 3
• 238000006206 glycosylation reaction Methods 0.000 description 3
• 231100000753 hepatic injury Toxicity 0.000 description 3
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 206010022000 influenza Diseases 0.000 description 3
• 230000000977 initiatory effect Effects 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 208000028867 ischemia Diseases 0.000 description 3
• 208000023589 ischemic disease Diseases 0.000 description 3
• 208000019423 liver disease Diseases 0.000 description 3
• 235000018977 lysine Nutrition 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 201000001441 melanoma Diseases 0.000 description 3
• 238000002844 melting Methods 0.000 description 3
• 230000008018 melting Effects 0.000 description 3
• 230000002503 metabolic effect Effects 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 208000031225 myocardial ischemia Diseases 0.000 description 3
• 230000003472 neutralizing effect Effects 0.000 description 3
• 210000002997 osteoclast Anatomy 0.000 description 3
• 230000002093 peripheral effect Effects 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 238000006366 phosphorylation reaction Methods 0.000 description 3
• 229920001451 polypropylene glycol Polymers 0.000 description 3
• 229920002451 polyvinyl alcohol Polymers 0.000 description 3
• 239000013641 positive control Substances 0.000 description 3
• 239000000843 powder Substances 0.000 description 3
• 239000002244 precipitate Substances 0.000 description 3
• 230000000069 prophylactic effect Effects 0.000 description 3
• 238000011321 prophylaxis Methods 0.000 description 3
• 238000003127 radioimmunoassay Methods 0.000 description 3
• 230000008929 regeneration Effects 0.000 description 3
• 238000011069 regeneration method Methods 0.000 description 3
• 238000012552 review Methods 0.000 description 3
• 206010051951 scimitar syndrome Diseases 0.000 description 3
• 239000011780 sodium chloride Substances 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 201000003120 testicular cancer Diseases 0.000 description 3
• 206010043554 thrombocytopenia Diseases 0.000 description 3
• 229940104230 thymidine Drugs 0.000 description 3
• 102000035160 transmembrane proteins Human genes 0.000 description 3
• 108091005703 transmembrane proteins Proteins 0.000 description 3
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
• 238000005829 trimerization reaction Methods 0.000 description 3
• 210000002700 urine Anatomy 0.000 description 3
• 210000005253 yeast cell Anatomy 0.000 description 3
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
• 208000003200 Adenoma Diseases 0.000 description 2
• 102000009027 Albumins Human genes 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• 206010002329 Aneurysm Diseases 0.000 description 2
• 206010002921 Aortitis Diseases 0.000 description 2
• 208000032467 Aplastic anaemia Diseases 0.000 description 2
• 208000031104 Arterial Occlusive disease Diseases 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 206010004659 Biliary cirrhosis Diseases 0.000 description 2
• 206010005003 Bladder cancer Diseases 0.000 description 2
• 201000006474 Brain Ischemia Diseases 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 208000033386 Buerger disease Diseases 0.000 description 2
• 125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
• 108010029697 CD40 Ligand Proteins 0.000 description 2
• 102100032937 CD40 ligand Human genes 0.000 description 2
• 101100230428 Caenorhabditis elegans hil-5 gene Proteins 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
• 206010007688 Carotid artery thrombosis Diseases 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 102000000844 Cell Surface Receptors Human genes 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
• 206010007953 Central nervous system lymphoma Diseases 0.000 description 2
• 206010008120 Cerebral ischaemia Diseases 0.000 description 2
• 208000005243 Chondrosarcoma Diseases 0.000 description 2
• 206010008909 Chronic Hepatitis Diseases 0.000 description 2
• 206010009900 Colitis ulcerative Diseases 0.000 description 2
• 108010042106 Collagen Type IX Proteins 0.000 description 2
• 102000004427 Collagen Type IX Human genes 0.000 description 2
• 108020004635 Complementary DNA Proteins 0.000 description 2
• 208000002330 Congenital Heart Defects Diseases 0.000 description 2
• 206010011091 Coronary artery thrombosis Diseases 0.000 description 2
• 102000053602 DNA Human genes 0.000 description 2
• 238000001712 DNA sequencing Methods 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 102000000541 Defensins Human genes 0.000 description 2
• 108010002069 Defensins Proteins 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 238000002965 ELISA Methods 0.000 description 2
• 208000005189 Embolism Diseases 0.000 description 2
• 201000009051 Embryonal Carcinoma Diseases 0.000 description 2
• 206010016654 Fibrosis Diseases 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 208000009329 Graft vs Host Disease Diseases 0.000 description 2
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 2
• 208000004196 Heart Aneurysm Diseases 0.000 description 2
• 101710154606 Hemagglutinin Proteins 0.000 description 2
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 2
• 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 2
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
• 206010020751 Hypersensitivity Diseases 0.000 description 2
• 208000010159 IgA glomerulonephritis Diseases 0.000 description 2
• 206010021263 IgA nephropathy Diseases 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000003996 Interferon-beta Human genes 0.000 description 2
• 108090000467 Interferon-beta Proteins 0.000 description 2
• 102000008070 Interferon-gamma Human genes 0.000 description 2
• 108010074328 Interferon-gamma Proteins 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 102100039064 Interleukin-3 Human genes 0.000 description 2
• 108010002335 Interleukin-9 Proteins 0.000 description 2
• 102000000585 Interleukin-9 Human genes 0.000 description 2
• 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 2
• 201000008450 Intracranial aneurysm Diseases 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• 208000003456 Juvenile Arthritis Diseases 0.000 description 2
• 208000034624 Leukocytoclastic Cutaneous Vasculitis Diseases 0.000 description 2
• 102000004882 Lipase Human genes 0.000 description 2
• 108090001060 Lipase Proteins 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
• 208000030289 Lymphoproliferative disease Diseases 0.000 description 2
• 239000004472 Lysine Substances 0.000 description 2
• 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 2
• 208000034578 Multiple myelomas Diseases 0.000 description 2
• 208000007201 Myocardial reperfusion injury Diseases 0.000 description 2
• 208000009525 Myocarditis Diseases 0.000 description 2
• 208000009567 Neonatal Alloimmune Thrombocytopenia Diseases 0.000 description 2
• 102100031903 Neudesin Human genes 0.000 description 2
• 101710090805 Neudesin Proteins 0.000 description 2
• 206010029260 Neuroblastoma Diseases 0.000 description 2
• 102100037142 Neuroblastoma suppressor of tumorigenicity 1 Human genes 0.000 description 2
• MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
• 208000022873 Ocular disease Diseases 0.000 description 2
• 102000004140 Oncostatin M Human genes 0.000 description 2
• 108090000630 Oncostatin M Proteins 0.000 description 2
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
• 206010057249 Phagocytosis Diseases 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
• 101710176177 Protein A56 Proteins 0.000 description 2
• 208000008640 Pulmonary Atresia Diseases 0.000 description 2
• 208000010378 Pulmonary Embolism Diseases 0.000 description 2
• 206010037549 Purpura Diseases 0.000 description 2
• 241001672981 Purpura Species 0.000 description 2
• 102000014128 RANK Ligand Human genes 0.000 description 2
• 108010025832 RANK Ligand Proteins 0.000 description 2
• 208000012322 Raynaud phenomenon Diseases 0.000 description 2
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
• 206010063837 Reperfusion injury Diseases 0.000 description 2
• 241000725643 Respiratory syncytial virus Species 0.000 description 2
• 206010038748 Restrictive cardiomyopathy Diseases 0.000 description 2
• 206010038933 Retinopathy of prematurity Diseases 0.000 description 2
• 102000006382 Ribonucleases Human genes 0.000 description 2
• 108010083644 Ribonucleases Proteins 0.000 description 2
• 108091028664 Ribonucleotide Proteins 0.000 description 2
• BFDMCHRDSYTOLE-UHFFFAOYSA-N SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 Chemical compound SC#N.NC(N)=N.ClC(Cl)Cl.OC1=CC=CC=C1 BFDMCHRDSYTOLE-UHFFFAOYSA-N 0.000 description 2
• 206010039710 Scleroderma Diseases 0.000 description 2
• 229920002684 Sepharose Polymers 0.000 description 2
• 206010040070 Septic Shock Diseases 0.000 description 2
• 108700028909 Serum Amyloid A Proteins 0.000 description 2
• 102000054727 Serum Amyloid A Human genes 0.000 description 2
• 102000013275 Somatomedins Human genes 0.000 description 2
• 108091081024 Start codon Proteins 0.000 description 2
• 208000005718 Stomach Neoplasms Diseases 0.000 description 2
• 208000001871 Tachycardia Diseases 0.000 description 2
• 206010057644 Testis cancer Diseases 0.000 description 2
• 206010043540 Thromboangiitis obliterans Diseases 0.000 description 2
• 208000007536 Thrombosis Diseases 0.000 description 2
• 108020004566 Transfer RNA Proteins 0.000 description 2
• 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 2
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 2
• 201000006704 Ulcerative Colitis Diseases 0.000 description 2
• 206010046851 Uveitis Diseases 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 230000001464 adherent effect Effects 0.000 description 2
• 230000001800 adrenalinergic effect Effects 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 125000001931 aliphatic group Chemical group 0.000 description 2
• 238000005804 alkylation reaction Methods 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 230000003460 anti-nuclear Effects 0.000 description 2
• 230000005875 antibody response Effects 0.000 description 2
• 206010003119 arrhythmia Diseases 0.000 description 2
• 230000006793 arrhythmia Effects 0.000 description 2
• 206010003230 arteritis Diseases 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 201000005000 autoimmune gastritis Diseases 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• 210000000013 bile duct Anatomy 0.000 description 2
• 229960002685 biotin Drugs 0.000 description 2
• 235000020958 biotin Nutrition 0.000 description 2
• 239000011616 biotin Substances 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 150000001720 carbohydrates Chemical group 0.000 description 2
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
• 239000013592 cell lysate Substances 0.000 description 2
• 108091092328 cellular RNA Proteins 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 208000025434 cerebellar degeneration Diseases 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 230000007882 cirrhosis Effects 0.000 description 2
• 208000019425 cirrhosis of liver Diseases 0.000 description 2
• 208000018912 cluster headache syndrome Diseases 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 230000001332 colony forming effect Effects 0.000 description 2
• 238000012875 competitive assay Methods 0.000 description 2
• 238000004590 computer program Methods 0.000 description 2
• 208000028831 congenital heart disease Diseases 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 208000006331 coronary aneurysm Diseases 0.000 description 2
• 208000029078 coronary artery disease Diseases 0.000 description 2
• 208000002528 coronary thrombosis Diseases 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 238000011461 current therapy Methods 0.000 description 2
• 208000002445 cystadenocarcinoma Diseases 0.000 description 2
• 201000001981 dermatomyositis Diseases 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 239000008121 dextrose Substances 0.000 description 2
• 238000010586 diagram Methods 0.000 description 2
• 238000000502 dialysis Methods 0.000 description 2
• 239000010432 diamond Substances 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 239000000539 dimer Substances 0.000 description 2
• 238000001962 electrophoresis Methods 0.000 description 2
• 210000001671 embryonic stem cell Anatomy 0.000 description 2
• 239000003995 emulsifying agent Substances 0.000 description 2
• 230000001804 emulsifying effect Effects 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 206010015037 epilepsy Diseases 0.000 description 2
• 230000029142 excretion Effects 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 239000012091 fetal bovine serum Substances 0.000 description 2
• 201000003444 follicular lymphoma Diseases 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 238000001641 gel filtration chromatography Methods 0.000 description 2
• 208000005017 glioblastoma Diseases 0.000 description 2
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
• 229910052737 gold Inorganic materials 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 208000018578 heart valve disease Diseases 0.000 description 2
• 208000007475 hemolytic anemia Diseases 0.000 description 2
• 231100000283 hepatitis Toxicity 0.000 description 2
• 229920001519 homopolymer Polymers 0.000 description 2
• 229940088597 hormone Drugs 0.000 description 2
• 239000005556 hormone Substances 0.000 description 2
• 210000004754 hybrid cell Anatomy 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 230000001969 hypertrophic effect Effects 0.000 description 2
• FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000007901 in situ hybridization Methods 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 208000000509 infertility Diseases 0.000 description 2
• 230000036512 infertility Effects 0.000 description 2
• 231100000535 infertility Toxicity 0.000 description 2
• 239000004615 ingredient Substances 0.000 description 2
• 229960003130 interferon gamma Drugs 0.000 description 2
• 229960001388 interferon-beta Drugs 0.000 description 2
• 201000007272 intracranial sinus thrombosis Diseases 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000004255 ion exchange chromatography Methods 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 208000017169 kidney disease Diseases 0.000 description 2
• 230000002147 killing effect Effects 0.000 description 2
• 208000004343 lateral medullary syndrome Diseases 0.000 description 2
• 238000007834 ligase chain reaction Methods 0.000 description 2
• 201000002818 limb ischemia Diseases 0.000 description 2
• 125000005647 linker group Chemical group 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 239000006166 lysate Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000036210 malignancy Effects 0.000 description 2
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
• 210000003622 mature neutrocyte Anatomy 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 230000031864 metaphase Effects 0.000 description 2
• 230000011987 methylation Effects 0.000 description 2
• 238000007069 methylation reaction Methods 0.000 description 2
• 210000000274 microglia Anatomy 0.000 description 2
• 230000037230 mobility Effects 0.000 description 2
• 239000000178 monomer Substances 0.000 description 2
• 210000002894 multi-fate stem cell Anatomy 0.000 description 2
• 208000030372 neonatal thrombocytopenia Diseases 0.000 description 2
• 201000008383 nephritis Diseases 0.000 description 2
• 208000015122 neurodegenerative disease Diseases 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 235000015097 nutrients Nutrition 0.000 description 2
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 201000008968 osteosarcoma Diseases 0.000 description 2
• 230000002611 ovarian Effects 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 201000002528 pancreatic cancer Diseases 0.000 description 2
• 208000008443 pancreatic carcinoma Diseases 0.000 description 2
• 208000004019 papillary adenocarcinoma Diseases 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 230000037361 pathway Effects 0.000 description 2
• 208000008494 pericarditis Diseases 0.000 description 2
• 210000005259 peripheral blood Anatomy 0.000 description 2
• 239000011886 peripheral blood Substances 0.000 description 2
• 230000008782 phagocytosis Effects 0.000 description 2
• 238000002205 phenol-chloroform extraction Methods 0.000 description 2
• 150000003906 phosphoinositides Chemical class 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 2
• 230000008488 polyadenylation Effects 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 230000004481 post-translational protein modification Effects 0.000 description 2
• 229920001592 potato starch Polymers 0.000 description 2
• 239000003755 preservative agent Substances 0.000 description 2
• 208000016800 primary central nervous system lymphoma Diseases 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 206010036807 progressive multifocal leukoencephalopathy Diseases 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• 230000004853 protein function Effects 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 238000002601 radiography Methods 0.000 description 2
• 239000011541 reaction mixture Substances 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
• 208000004644 retinal vein occlusion Diseases 0.000 description 2
• 208000004124 rheumatic heart disease Diseases 0.000 description 2
• 239000002336 ribonucleotide Substances 0.000 description 2
• 125000002652 ribonucleotide group Chemical group 0.000 description 2
• 102220279132 rs143212932 Human genes 0.000 description 2
• 210000003296 saliva Anatomy 0.000 description 2
• 238000005185 salting out Methods 0.000 description 2
• 230000036303 septic shock Effects 0.000 description 2
• 208000000587 small cell lung carcinoma Diseases 0.000 description 2
• 229940126586 small molecule drug Drugs 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 201000011549 stomach cancer Diseases 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 208000023516 stroke disease Diseases 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 238000001356 surgical procedure Methods 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 230000006794 tachycardia Effects 0.000 description 2
• 230000002463 transducing effect Effects 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 208000007340 tricuspid atresia Diseases 0.000 description 2
• 238000000108 ultra-filtration Methods 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 229940035893 uracil Drugs 0.000 description 2
• 238000002255 vaccination Methods 0.000 description 2
• 210000003462 vein Anatomy 0.000 description 2
• 230000035899 viability Effects 0.000 description 2
• 239000000080 wetting agent Substances 0.000 description 2
• 230000029663 wound healing Effects 0.000 description 2
• 238000001086 yeast two-hybrid system Methods 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• FQERLIOIVXPZKH-UHFFFAOYSA-N 1,2,4-trioxane Chemical compound C1COOCO1 FQERLIOIVXPZKH-UHFFFAOYSA-N 0.000 description 1
• WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
• CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
• JECYNCQXXKQDJN-UHFFFAOYSA-N 2-(2-methylhexan-2-yloxymethyl)oxirane Chemical compound CCCCC(C)(C)OCC1CO1 JECYNCQXXKQDJN-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
• 102000002627 4-1BB Ligand Human genes 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
• 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
• 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 1
• 108091007505 ADAM17 Proteins 0.000 description 1
• 230000005730 ADP ribosylation Effects 0.000 description 1
• 208000001193 Accelerated Idioventricular Rhythm Diseases 0.000 description 1
• 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 206010000830 Acute leukaemia Diseases 0.000 description 1
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
• 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 1
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
• 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
• 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
• 206010001115 Adams-Stokes syndrome Diseases 0.000 description 1
• 208000026872 Addison Disease Diseases 0.000 description 1
• 206010001233 Adenoma benign Diseases 0.000 description 1
• 208000010370 Adenoviridae Infections Diseases 0.000 description 1
• 206010060931 Adenovirus infection Diseases 0.000 description 1
• 208000008190 Agammaglobulinemia Diseases 0.000 description 1
• 206010001526 Air embolism Diseases 0.000 description 1
• 201000010053 Alcoholic Cardiomyopathy Diseases 0.000 description 1
• 208000032671 Allergic granulomatous angiitis Diseases 0.000 description 1
• 102100022463 Alpha-1-acid glycoprotein 1 Human genes 0.000 description 1
• 101710186701 Alpha-1-acid glycoprotein 1 Proteins 0.000 description 1
• 102100022460 Alpha-1-acid glycoprotein 2 Human genes 0.000 description 1
• 101710186699 Alpha-1-acid glycoprotein 2 Proteins 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 208000005952 Amniotic Fluid Embolism Diseases 0.000 description 1
• 206010002198 Anaphylactic reaction Diseases 0.000 description 1
• 206010002383 Angina Pectoris Diseases 0.000 description 1
• 208000004375 Angiodysplasia Diseases 0.000 description 1
• 208000028185 Angioedema Diseases 0.000 description 1
• 208000003120 Angiofibroma Diseases 0.000 description 1
• 201000003076 Angiosarcoma Diseases 0.000 description 1
• 108010049777 Ankyrins Proteins 0.000 description 1
• 102000008102 Ankyrins Human genes 0.000 description 1
• 108010032595 Antibody Binding Sites Proteins 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
• 208000026828 Aorta coarctation Diseases 0.000 description 1
• 208000006179 Aortic Coarctation Diseases 0.000 description 1
• 208000003017 Aortic Valve Stenosis Diseases 0.000 description 1
• 208000025494 Aortic disease Diseases 0.000 description 1
• 206010002915 Aortic valve incompetence Diseases 0.000 description 1
• 206010057454 Aortic valve prolapse Diseases 0.000 description 1
• 208000009771 Aortopulmonary Septal Defect Diseases 0.000 description 1
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
• 102000009081 Apolipoprotein A-II Human genes 0.000 description 1
• 108010087614 Apolipoprotein A-II Proteins 0.000 description 1
• 101710095342 Apolipoprotein B Proteins 0.000 description 1
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
• 102000030169 Apolipoprotein C-III Human genes 0.000 description 1
• 108010056301 Apolipoprotein C-III Proteins 0.000 description 1
• 102100022954 Apolipoprotein D Human genes 0.000 description 1
• 102100029470 Apolipoprotein E Human genes 0.000 description 1
• 101710095339 Apolipoprotein E Proteins 0.000 description 1
• 108010025614 Apolipoproteins D Proteins 0.000 description 1
• 101100020268 Arabidopsis thaliana KIN4A gene Proteins 0.000 description 1
• IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 208000008092 Arterio-Arterial Fistula Diseases 0.000 description 1
• 206010003210 Arteriosclerosis Diseases 0.000 description 1
• 206010003225 Arteriospasm coronary Diseases 0.000 description 1
• 206010003226 Arteriovenous fistula Diseases 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
• 201000001320 Atherosclerosis Diseases 0.000 description 1
• 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
• 206010003658 Atrial Fibrillation Diseases 0.000 description 1
• 206010003662 Atrial flutter Diseases 0.000 description 1
• 208000006808 Atrioventricular Nodal Reentry Tachycardia Diseases 0.000 description 1
• 206010063836 Atrioventricular septal defect Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
• 238000012935 Averaging Methods 0.000 description 1
• 241000713826 Avian leukosis virus Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 208000004597 Bacillary angiomatosis Diseases 0.000 description 1
• 206010004146 Basal cell carcinoma Diseases 0.000 description 1
• 208000027496 Behcet disease Diseases 0.000 description 1
• 206010061692 Benign muscle neoplasm Diseases 0.000 description 1
• 102100030802 Beta-2-glycoprotein 1 Human genes 0.000 description 1
• 101710180007 Beta-2-glycoprotein 1 Proteins 0.000 description 1
• 206010004593 Bile duct cancer Diseases 0.000 description 1
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 1
• 208000019838 Blood disease Diseases 0.000 description 1
• 206010059126 Blue toe syndrome Diseases 0.000 description 1
• 208000010392 Bone Fractures Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 208000002381 Brain Hypoxia Diseases 0.000 description 1
• 208000007257 Budd-Chiari syndrome Diseases 0.000 description 1
• 206010006578 Bundle-Branch Block Diseases 0.000 description 1
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
• 101710112613 C-C motif chemokine 13 Proteins 0.000 description 1
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 108010074051 C-Reactive Protein Proteins 0.000 description 1
• 102100032752 C-reactive protein Human genes 0.000 description 1
• 102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
• 101710167766 C-type lectin domain family 11 member A Proteins 0.000 description 1
• 102000007499 CD27 Ligand Human genes 0.000 description 1
• 108010046080 CD27 Ligand Proteins 0.000 description 1
• 102100027207 CD27 antigen Human genes 0.000 description 1
• 102000004634 CD30 Ligand Human genes 0.000 description 1
• 108010017987 CD30 Ligand Proteins 0.000 description 1
• 101150013553 CD40 gene Proteins 0.000 description 1
• 102100026862 CD5 antigen-like Human genes 0.000 description 1
• 101710122347 CD5 antigen-like Proteins 0.000 description 1
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
• 201000002829 CREST Syndrome Diseases 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 102000005367 Carboxypeptidases Human genes 0.000 description 1
• 108010006303 Carboxypeptidases Proteins 0.000 description 1
• 208000009447 Cardiac Edema Diseases 0.000 description 1
• 208000006017 Cardiac Tamponade Diseases 0.000 description 1
• 206010007559 Cardiac failure congestive Diseases 0.000 description 1
• 208000006029 Cardiomegaly Diseases 0.000 description 1
• 206010007637 Cardiomyopathy alcoholic Diseases 0.000 description 1
• 208000004652 Cardiovascular Abnormalities Diseases 0.000 description 1
• 208000004873 Cardiovascular Pregnancy Complications Diseases 0.000 description 1
• 208000000135 Cardiovascular Syphilis Diseases 0.000 description 1
• 208000000431 Cardiovascular Tuberculosis Diseases 0.000 description 1
• 208000014882 Carotid artery disease Diseases 0.000 description 1
• 229930186147 Cephalosporin Natural products 0.000 description 1
• 208000021910 Cerebral Arterial disease Diseases 0.000 description 1
• 208000005145 Cerebral amyloid angiopathy Diseases 0.000 description 1
• 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
• 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
• 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 208000000425 Chagas Cardiomyopathy Diseases 0.000 description 1
• 108010009685 Cholinergic Receptors Proteins 0.000 description 1
• 201000009047 Chordoma Diseases 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 208000005590 Choroidal Neovascularization Diseases 0.000 description 1
• 206010060823 Choroidal neovascularisation Diseases 0.000 description 1
• 208000030939 Chronic inflammatory demyelinating polyneuropathy Diseases 0.000 description 1
• 208000006344 Churg-Strauss Syndrome Diseases 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 102100023335 Chymotrypsin-like elastase family member 2A Human genes 0.000 description 1
• 208000032544 Cicatrix Diseases 0.000 description 1
• 208000006561 Cluster Headache Diseases 0.000 description 1
• 206010009807 Coarctation of the aorta Diseases 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 206010009895 Colitis ischaemic Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 102100031609 Complement C2 Human genes 0.000 description 1
• 108090000955 Complement C2 Proteins 0.000 description 1
• 108010028777 Complement C8 Proteins 0.000 description 1
• 102000016550 Complement Factor H Human genes 0.000 description 1
• 108010053085 Complement Factor H Proteins 0.000 description 1
• 102100040492 Complement component C8 gamma chain Human genes 0.000 description 1
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 1
• 108020004394 Complementary RNA Proteins 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 206010010904 Convulsion Diseases 0.000 description 1
• 201000006306 Cor pulmonale Diseases 0.000 description 1
• 206010010972 Cor triatriatum Diseases 0.000 description 1
• 208000003890 Coronary Vasospasm Diseases 0.000 description 1
• 208000005009 Coronary Vessel Anomalies Diseases 0.000 description 1
• 208000009798 Craniopharyngioma Diseases 0.000 description 1
• 208000004725 Crisscross Heart Diseases 0.000 description 1
• 102000006311 Cyclin D1 Human genes 0.000 description 1
• 108010058546 Cyclin D1 Proteins 0.000 description 1
• 201000003883 Cystic fibrosis Diseases 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Polymers OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 239000003155 DNA primer Substances 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 102000010170 Death domains Human genes 0.000 description 1
• 108050001718 Death domains Proteins 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 206010012438 Dermatitis atopic Diseases 0.000 description 1
• YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
• 208000002249 Diabetes Complications Diseases 0.000 description 1
• 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
• 206010012655 Diabetic complications Diseases 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• 102100037986 Dickkopf-related protein 4 Human genes 0.000 description 1
• 101710099554 Dickkopf-related protein 4 Proteins 0.000 description 1
• 201000010046 Dilated cardiomyopathy Diseases 0.000 description 1
• 102100031111 Disintegrin and metalloproteinase domain-containing protein 17 Human genes 0.000 description 1
• 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
• 206010013611 Double outlet right ventricle Diseases 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101001125114 Drosophila melanogaster PRL-1 phosphatase Proteins 0.000 description 1
• 208000001654 Drug Resistant Epilepsy Diseases 0.000 description 1
• 206010013700 Drug hypersensitivity Diseases 0.000 description 1
• 102000000327 E2F4 Transcription Factor Human genes 0.000 description 1
• 108010016085 E2F4 Transcription Factor Proteins 0.000 description 1
• 101150059079 EBNA1 gene Proteins 0.000 description 1
• 201000006660 Ebstein Anomaly Diseases 0.000 description 1
• 102100029722 Ectonucleoside triphosphate diphosphohydrolase 1 Human genes 0.000 description 1
• 208000000730 Ectopic Atrial Tachycardia Diseases 0.000 description 1
• 208000005525 Ectopic Junctional Tachycardia Diseases 0.000 description 1
• 208000003287 Eisenmenger Complex Diseases 0.000 description 1
• 208000007228 Endocardial Cushion Defects Diseases 0.000 description 1
• 201000009273 Endometriosis Diseases 0.000 description 1
• 208000018428 Eosinophilic granulomatosis with polyangiitis Diseases 0.000 description 1
• 206010014967 Ependymoma Diseases 0.000 description 1
• 101800003838 Epidermal growth factor Proteins 0.000 description 1
• 102400001368 Epidermal growth factor Human genes 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 208000031637 Erythroblastic Acute Leukemia Diseases 0.000 description 1
• 208000036566 Erythroleukaemia Diseases 0.000 description 1
• 102000003951 Erythropoietin Human genes 0.000 description 1
• 108090000394 Erythropoietin Proteins 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
• 208000006168 Ewing Sarcoma Diseases 0.000 description 1
• 208000010201 Exanthema Diseases 0.000 description 1
• 108050001049 Extracellular proteins Proteins 0.000 description 1
• 206010015769 Extradural haematoma Diseases 0.000 description 1
• 101150032593 FOSL1 gene Proteins 0.000 description 1
• 208000023281 Fallot tetralogy Diseases 0.000 description 1
• 208000009087 False Aneurysm Diseases 0.000 description 1
• 208000003241 Fat Embolism Diseases 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• 102100040977 Follitropin subunit beta Human genes 0.000 description 1
• 101710203050 Follitropin subunit beta Proteins 0.000 description 1
• 102100023372 Fos-related antigen 1 Human genes 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 102000013382 Gelatinases Human genes 0.000 description 1
• 108010026132 Gelatinases Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 208000002966 Giant Cell Tumor of Bone Diseases 0.000 description 1
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 1
• 208000010412 Glaucoma Diseases 0.000 description 1
• 208000032612 Glial tumor Diseases 0.000 description 1
• 206010018338 Glioma Diseases 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
• 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 1
• 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 1
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 1
• 108010078321 Guanylate Cyclase Proteins 0.000 description 1
• 102000014469 Guanylate cyclase Human genes 0.000 description 1
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
• 102000014702 Haptoglobin Human genes 0.000 description 1
• 108050005077 Haptoglobin Proteins 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• 208000035211 Heart Murmurs Diseases 0.000 description 1
• 206010019280 Heart failures Diseases 0.000 description 1
• 206010019375 Helicobacter infections Diseases 0.000 description 1
• 208000001258 Hemangiosarcoma Diseases 0.000 description 1
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
• 102000013271 Hemopexin Human genes 0.000 description 1
• 108010026027 Hemopexin Proteins 0.000 description 1
• 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 230000010556 Heparin Binding Activity Effects 0.000 description 1
• 206010019713 Hepatic vein thrombosis Diseases 0.000 description 1
• 206010019755 Hepatitis chronic active Diseases 0.000 description 1
• 208000031953 Hereditary hemorrhagic telangiectasia Diseases 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
• 208000006148 High Cardiac Output Diseases 0.000 description 1
• 102100027619 Histidine-rich glycoprotein Human genes 0.000 description 1
• 108010033040 Histones Proteins 0.000 description 1
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 1
• 101000907955 Homo sapiens Chymotrypsin-like elastase family member 2A Proteins 0.000 description 1
• 101001012447 Homo sapiens Ectonucleoside triphosphate diphosphohydrolase 1 Proteins 0.000 description 1
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 1
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
• 101000972485 Homo sapiens Lupus La protein Proteins 0.000 description 1
• 101000602237 Homo sapiens Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
• 101000830696 Homo sapiens Protein tyrosine phosphatase type IVA 1 Proteins 0.000 description 1
• 101000815628 Homo sapiens Regulatory-associated protein of mTOR Proteins 0.000 description 1
• 101000652747 Homo sapiens Target of rapamycin complex 2 subunit MAPKAP1 Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• 101000648491 Homo sapiens Transportin-1 Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 241001135569 Human adenovirus 5 Species 0.000 description 1
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
• 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000701041 Human betaherpesvirus 7 Species 0.000 description 1
• 241000701027 Human herpesvirus 6 Species 0.000 description 1
• 241000702617 Human parvovirus B19 Species 0.000 description 1
• 206010020565 Hyperaemia Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 206010020983 Hypogammaglobulinaemia Diseases 0.000 description 1
• 206010062767 Hypophysitis Diseases 0.000 description 1
• 201000005503 Hypoplastic left heart syndrome Diseases 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
• 208000031814 IgA Vasculitis Diseases 0.000 description 1
• 208000008952 Iliac Aneurysm Diseases 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
• 208000000523 Infected Aneurysm Diseases 0.000 description 1
• 208000029534 Infectious Bone disease Diseases 0.000 description 1
• 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 description 1
• 108010001127 Insulin Receptor Proteins 0.000 description 1
• 206010022489 Insulin Resistance Diseases 0.000 description 1
• 102100036721 Insulin receptor Human genes 0.000 description 1
• 102100025947 Insulin-like growth factor II Human genes 0.000 description 1
• 102000004375 Insulin-like growth factor-binding protein 1 Human genes 0.000 description 1
• 108090000957 Insulin-like growth factor-binding protein 1 Proteins 0.000 description 1
• 101800001691 Inter-alpha-trypsin inhibitor light chain Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
• 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 102000004556 Interleukin-15 Receptors Human genes 0.000 description 1
• 108010017535 Interleukin-15 Receptors Proteins 0.000 description 1
• 108010017525 Interleukin-17 Receptors Proteins 0.000 description 1
• 102000004554 Interleukin-17 Receptors Human genes 0.000 description 1
• 102000003810 Interleukin-18 Human genes 0.000 description 1
• 108090000171 Interleukin-18 Proteins 0.000 description 1
• 102000004557 Interleukin-18 Receptors Human genes 0.000 description 1
• 108010017537 Interleukin-18 Receptors Proteins 0.000 description 1
• 108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
• 102000010787 Interleukin-4 Receptors Human genes 0.000 description 1
• 102100039897 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 206010022562 Intermittent claudication Diseases 0.000 description 1
• 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
• 208000005313 Intracranial Embolism and Thrombosis Diseases 0.000 description 1
• 206010065630 Iris neovascularisation Diseases 0.000 description 1
• 101150026829 JUNB gene Proteins 0.000 description 1
• 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
• 208000007766 Kaposi sarcoma Diseases 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• 206010048804 Kearns-Sayre syndrome Diseases 0.000 description 1
• 208000000588 Klippel-Trenaunay-Weber Syndrome Diseases 0.000 description 1
• 208000034642 Klippel-Trénaunay syndrome Diseases 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
• 102000004407 Lactalbumin Human genes 0.000 description 1
• 108090000942 Lactalbumin Proteins 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 206010071015 Laevocardia Diseases 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
• 208000018142 Leiomyosarcoma Diseases 0.000 description 1
• 208000002364 Leriche syndrome Diseases 0.000 description 1
• SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 description 1
• VPKIQULSKFVCSM-SRVKXCTJSA-N Leu-Gln-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VPKIQULSKFVCSM-SRVKXCTJSA-N 0.000 description 1
• 240000007472 Leucaena leucocephala Species 0.000 description 1
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
• 206010024305 Leukaemia monocytic Diseases 0.000 description 1
• 208000032514 Leukocytoclastic vasculitis Diseases 0.000 description 1
• 102000019298 Lipocalin Human genes 0.000 description 1
• 108050006654 Lipocalin Proteins 0.000 description 1
• 102000003752 Lipocalin 1 Human genes 0.000 description 1
• 108010057281 Lipocalin 1 Proteins 0.000 description 1
• 208000009378 Low Cardiac Output Diseases 0.000 description 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
• 208000009416 Lown-Ganong-Levine Syndrome Diseases 0.000 description 1
• 102100022742 Lupus La protein Human genes 0.000 description 1
• 208000004229 Lutembacher syndrome Diseases 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 206010025327 Lymphopenia Diseases 0.000 description 1
• 102000043129 MHC class I family Human genes 0.000 description 1
• 108091054437 MHC class I family Proteins 0.000 description 1
• 102000043131 MHC class II family Human genes 0.000 description 1
• 108091054438 MHC class II family Proteins 0.000 description 1
• 208000002076 Mahaim-Type Pre-Excitation Diseases 0.000 description 1
• PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102100026553 Mannose-binding protein C Human genes 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 208000007054 Medullary Carcinoma Diseases 0.000 description 1
• 208000000172 Medulloblastoma Diseases 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 206010027406 Mesothelioma Diseases 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 108091092878 Microsatellite Proteins 0.000 description 1
• 108091092919 Minisatellite Proteins 0.000 description 1
• 208000003430 Mitral Valve Prolapse Diseases 0.000 description 1
• 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
• 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
• 208000003250 Mixed connective tissue disease Diseases 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 208000009433 Moyamoya Disease Diseases 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101000845218 Mus musculus Thymic stromal lymphopoietin Proteins 0.000 description 1
• 108010021466 Mutant Proteins Proteins 0.000 description 1
• 102000008300 Mutant Proteins Human genes 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 241000713883 Myeloproliferative sarcoma virus Species 0.000 description 1
• 208000021908 Myocardial disease Diseases 0.000 description 1
• 201000004458 Myoma Diseases 0.000 description 1
• 201000002481 Myositis Diseases 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• 208000025696 NK cell deficiency Diseases 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 206010029240 Neuritis Diseases 0.000 description 1
• 101710120296 Neuroblastoma suppressor of tumorigenicity 1 Proteins 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 208000025047 Non-histaminic angioedema Diseases 0.000 description 1
• 108010051791 Nuclear Antigens Proteins 0.000 description 1
• 102000019040 Nuclear Antigens Human genes 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
• 102000004473 OX40 Ligand Human genes 0.000 description 1
• 108010042215 OX40 Ligand Proteins 0.000 description 1
• 201000010133 Oligodendroglioma Diseases 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 208000007117 Oral Ulcer Diseases 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 208000001715 Osteoblastoma Diseases 0.000 description 1
• 108010035042 Osteoprotegerin Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 208000002193 Pain Diseases 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 208000009608 Papillomavirus Infections Diseases 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 208000006679 Parasystole Diseases 0.000 description 1
• 208000004327 Paroxysmal Dyspnea Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 206010034277 Pemphigoid Diseases 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 208000005228 Pericardial Effusion Diseases 0.000 description 1
• 208000018262 Peripheral vascular disease Diseases 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 208000004605 Persistent Truncus Arteriosus Diseases 0.000 description 1
• 102100037883 Phospholipase B1, membrane-associated Human genes 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 206010034972 Photosensitivity reaction Diseases 0.000 description 1
• 208000007641 Pinealoma Diseases 0.000 description 1
• 102100024078 Plasma serine protease inhibitor Human genes 0.000 description 1
• 101710183733 Plasma serine protease inhibitor Proteins 0.000 description 1
• 206010035664 Pneumonia Diseases 0.000 description 1
• 206010048731 Pneumopericardium Diseases 0.000 description 1
• 206010065159 Polychondritis Diseases 0.000 description 1
• 208000025237 Polyendocrinopathy Diseases 0.000 description 1
• 239000004698 Polyethylene Substances 0.000 description 1
• 208000004808 Post-Infarction Heart Rupture Diseases 0.000 description 1
• 208000004347 Postpericardiotomy Syndrome Diseases 0.000 description 1
• 208000005585 Poxviridae Infections Diseases 0.000 description 1
• 108010071690 Prealbumin Proteins 0.000 description 1
• 102000007584 Prealbumin Human genes 0.000 description 1
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
• 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 1
• 102000035554 Proglucagon Human genes 0.000 description 1
• 108010058003 Proglucagon Proteins 0.000 description 1
• 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102100032859 Protein AMBP Human genes 0.000 description 1
• 102100036352 Protein disulfide-isomerase Human genes 0.000 description 1
• 102100024599 Protein tyrosine phosphatase type IVA 1 Human genes 0.000 description 1
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• 241000125945 Protoparvovirus Species 0.000 description 1
• 108091008109 Pseudogenes Proteins 0.000 description 1
• 102000057361 Pseudogenes Human genes 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• 208000020410 Psoriasis-related juvenile idiopathic arthritis Diseases 0.000 description 1
• 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
• 201000004252 Pulmonary Subvalvular Stenosis Diseases 0.000 description 1
• 206010037448 Pulmonary valve incompetence Diseases 0.000 description 1
• 208000014777 Pulmonary venoocclusive disease Diseases 0.000 description 1
• 206010037649 Pyogenic granuloma Diseases 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 239000012614 Q-Sepharose Substances 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000003782 Raynaud disease Diseases 0.000 description 1
• 230000010799 Receptor Interactions Effects 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 102100040969 Regulatory-associated protein of mTOR Human genes 0.000 description 1
• 208000035415 Reinfection Diseases 0.000 description 1
• 208000033464 Reiter syndrome Diseases 0.000 description 1
• 208000004531 Renal Artery Obstruction Diseases 0.000 description 1
• 208000006265 Renal cell carcinoma Diseases 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 201000007527 Retinal artery occlusion Diseases 0.000 description 1
• 206010038910 Retinitis Diseases 0.000 description 1
• 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
• 102100038246 Retinol-binding protein 4 Human genes 0.000 description 1
• 101710137011 Retinol-binding protein 4 Proteins 0.000 description 1
• 102000004389 Ribonucleoproteins Human genes 0.000 description 1
• 108010081734 Ribonucleoproteins Proteins 0.000 description 1
• 208000000924 Right ventricular hypertrophy Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 208000004717 Ruptured Aneurysm Diseases 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 101100227696 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FRA1 gene Proteins 0.000 description 1
• 102000018968 Salivary Cystatins Human genes 0.000 description 1
• 108010026774 Salivary Cystatins Proteins 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• 201000010208 Seminoma Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 206010058556 Serositis Diseases 0.000 description 1
• 108010045517 Serum Amyloid P-Component Proteins 0.000 description 1
• 102100036202 Serum amyloid P-component Human genes 0.000 description 1
• 206010040639 Sick sinus syndrome Diseases 0.000 description 1
• 208000001770 Sinoatrial Nodal Reentry Tachycardia Diseases 0.000 description 1
• 206010040736 Sinoatrial block Diseases 0.000 description 1
• 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
• 208000007888 Sinus Tachycardia Diseases 0.000 description 1
• 206010041067 Small cell lung cancer Diseases 0.000 description 1
• 102100022831 Somatoliberin Human genes 0.000 description 1
• 101710142969 Somatoliberin Proteins 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Polymers OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000713896 Spleen necrosis virus Species 0.000 description 1
• 241000256248 Spodoptera Species 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 102000014284 Statherin Human genes 0.000 description 1
• 108050003162 Statherin Proteins 0.000 description 1
• 108010039445 Stem Cell Factor Proteins 0.000 description 1
• 206010072148 Stiff-Person syndrome Diseases 0.000 description 1
• 108010023197 Streptokinase Proteins 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 206010042265 Sturge-Weber Syndrome Diseases 0.000 description 1
• 208000032851 Subarachnoid Hemorrhage Diseases 0.000 description 1
• 201000006561 Subclavian Steal Syndrome Diseases 0.000 description 1
• 208000002667 Subdural Hematoma Diseases 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 208000001122 Superior Vena Cava Syndrome Diseases 0.000 description 1
• 208000003734 Supraventricular Tachycardia Diseases 0.000 description 1
• 230000010782 T cell mediated cytotoxicity Effects 0.000 description 1
• 230000024932 T cell mediated immunity Effects 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 210000000173 T-lymphoid precursor cell Anatomy 0.000 description 1
• 108700012920 TNF Proteins 0.000 description 1
• 108010000449 TNF-Related Apoptosis-Inducing Ligand Receptors Proteins 0.000 description 1
• 102000002259 TNF-Related Apoptosis-Inducing Ligand Receptors Human genes 0.000 description 1
• 101150056647 TNFRSF4 gene Proteins 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• 206010043189 Telangiectasia Diseases 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 201000003005 Tetralogy of Fallot Diseases 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000036693 Thrombopoietin Human genes 0.000 description 1
• 108010041111 Thrombopoietin Proteins 0.000 description 1
• 108090000253 Thyrotropin Receptors Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 208000018452 Torsade de pointes Diseases 0.000 description 1
• 208000002363 Torsades de Pointes Diseases 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 208000003441 Transfusion reaction Diseases 0.000 description 1
• 208000002148 Transposition of Great Vessels Diseases 0.000 description 1
• 206010044443 Transposition of the great vessels Diseases 0.000 description 1
• 208000013565 Triatrial heart Diseases 0.000 description 1
• 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 1
• 206010044642 Tricuspid valve stenosis Diseases 0.000 description 1
• 208000003528 Trilogy of Fallot Diseases 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 108090000631 Trypsin Proteins 0.000 description 1
• 102000004142 Trypsin Human genes 0.000 description 1
• 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• YJQCOFNZVFGCAF-UHFFFAOYSA-N Tunicamycin II Natural products O1C(CC(O)C2C(C(O)C(O2)N2C(NC(=O)C=C2)=O)O)C(O)C(O)C(NC(=O)C=CCCCCCCCCC(C)C)C1OC1OC(CO)C(O)C(O)C1NC(C)=O YJQCOFNZVFGCAF-UHFFFAOYSA-N 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000024780 Urticaria Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 208000000558 Varicose Ulcer Diseases 0.000 description 1
• 206010046996 Varicose vein Diseases 0.000 description 1
• 208000001407 Vascular Headaches Diseases 0.000 description 1
• 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
• 101710120667 Vasopressin-neurophysin 2-copeptin Proteins 0.000 description 1
• 208000009982 Ventricular Dysfunction Diseases 0.000 description 1
• 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
• 208000006057 Ventricular Septal Rupture Diseases 0.000 description 1
• 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 1
• 208000014070 Vestibular schwannoma Diseases 0.000 description 1
• 206010047642 Vitiligo Diseases 0.000 description 1
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
• 208000013058 Weber syndrome Diseases 0.000 description 1
• 208000008383 Wilms tumor Diseases 0.000 description 1
• 201000008803 Wolff-Parkinson-white syndrome Diseases 0.000 description 1
• 206010052428 Wound Diseases 0.000 description 1
• 230000001436 acantholytic effect Effects 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 102000034337 acetylcholine receptors Human genes 0.000 description 1
• 208000004064 acoustic neuroma Diseases 0.000 description 1
• 208000017733 acquired polycythemia vera Diseases 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 208000021841 acute erythroid leukemia Diseases 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
• 238000004115 adherent culture Methods 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
• 210000004504 adult stem cell Anatomy 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 238000001042 affinity chromatography Methods 0.000 description 1
• 239000007801 affinity label Substances 0.000 description 1
• 230000032683 aging Effects 0.000 description 1
• 235000004279 alanine Nutrition 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 125000003172 aldehyde group Chemical group 0.000 description 1
• 125000003545 alkoxy group Chemical group 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• 201000009961 allergic asthma Diseases 0.000 description 1
• 201000002331 allergic cutaneous vasculitis Diseases 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
• 230000001668 ameliorated effect Effects 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 235000011130 ammonium sulphate Nutrition 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 230000036783 anaphylactic response Effects 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 208000000252 angiomatosis Diseases 0.000 description 1
• 208000012948 angioosteohypertrophic syndrome Diseases 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 201000005265 anterior compartment syndrome Diseases 0.000 description 1
• 230000003367 anti-collagen effect Effects 0.000 description 1
• 230000003172 anti-dna Effects 0.000 description 1
• 230000002924 anti-infective effect Effects 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 230000007503 antigenic stimulation Effects 0.000 description 1
• 239000000074 antisense oligonucleotide Substances 0.000 description 1
• 238000012230 antisense oligonucleotides Methods 0.000 description 1
• 230000007416 antiviral immune response Effects 0.000 description 1
• 208000007474 aortic aneurysm Diseases 0.000 description 1
• 206010002906 aortic stenosis Diseases 0.000 description 1
• 201000002064 aortic valve insufficiency Diseases 0.000 description 1
• 208000016709 aortopulmonary window Diseases 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
• 238000007080 aromatic substitution reaction Methods 0.000 description 1
• 208000011775 arteriosclerosis disease Diseases 0.000 description 1
• 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 125000004104 aryloxy group Chemical group 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• 201000008937 atopic dermatitis Diseases 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• 230000002238 attenuated effect Effects 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 238000011888 autopsy Methods 0.000 description 1
• 229910052788 barium Inorganic materials 0.000 description 1
• DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
• 210000002469 basement membrane Anatomy 0.000 description 1
• 102000015736 beta 2-Microglobulin Human genes 0.000 description 1
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 1
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
• 201000007180 bile duct carcinoma Diseases 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 238000010256 biochemical assay Methods 0.000 description 1
• 239000013060 biological fluid Substances 0.000 description 1
• 201000001531 bladder carcinoma Diseases 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 238000010322 bone marrow transplantation Methods 0.000 description 1
• 230000010072 bone remodeling Effects 0.000 description 1
• 230000036471 bradycardia Effects 0.000 description 1
• 208000006218 bradycardia Diseases 0.000 description 1
• 201000007293 brain stem infarction Diseases 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 210000000424 bronchial epithelial cell Anatomy 0.000 description 1
• 208000003362 bronchogenic carcinoma Diseases 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 208000000594 bullous pemphigoid Diseases 0.000 description 1
• 238000010804 cDNA synthesis Methods 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
• 230000004094 calcium homeostasis Effects 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 238000009566 cancer vaccine Methods 0.000 description 1
• 229940022399 cancer vaccine Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 208000005761 carcinoid heart disease Diseases 0.000 description 1
• 201000004827 cardiac tuberculosis Diseases 0.000 description 1
• 208000006170 carotid stenosis Diseases 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000005277 cation exchange chromatography Methods 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000011712 cell development Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 229940124587 cephalosporin Drugs 0.000 description 1
• 150000001780 cephalosporins Chemical class 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 208000007413 cholesterol embolism Diseases 0.000 description 1
• 239000012504 chromatography matrix Substances 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• 238000003200 chromosome mapping Methods 0.000 description 1
• 208000019069 chronic childhood arthritis Diseases 0.000 description 1
• 201000005795 chronic inflammatory demyelinating polyneuritis Diseases 0.000 description 1
• 208000024207 chronic leukemia Diseases 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 230000035071 co-translational protein modification Effects 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 102000005311 colipase Human genes 0.000 description 1
• 108020002632 colipase Proteins 0.000 description 1
• 210000001072 colon Anatomy 0.000 description 1
• 230000000112 colonic effect Effects 0.000 description 1
• 230000005757 colony formation Effects 0.000 description 1
• 206010010121 compartment syndrome Diseases 0.000 description 1
• 230000006957 competitive inhibition Effects 0.000 description 1
• 230000024203 complement activation Effects 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 201000011634 coronary artery vasospasm Diseases 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000003412 degenerative effect Effects 0.000 description 1
• 230000003111 delayed effect Effects 0.000 description 1
• 229910052805 deuterium Inorganic materials 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 208000001166 dextrocardia Diseases 0.000 description 1
• 201000009101 diabetic angiopathy Diseases 0.000 description 1
• 208000033679 diabetic kidney disease Diseases 0.000 description 1
• 239000000385 dialysis solution Substances 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• 230000000447 dimerizing effect Effects 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 206010014663 endocardial fibroelastosis Diseases 0.000 description 1
• 206010014665 endocarditis Diseases 0.000 description 1
• 210000003372 endocrine gland Anatomy 0.000 description 1
• 201000010048 endomyocardial fibrosis Diseases 0.000 description 1
• 206010014801 endophthalmitis Diseases 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 229940116977 epidermal growth factor Drugs 0.000 description 1
• 208000037828 epithelial carcinoma Diseases 0.000 description 1
• 210000003743 erythrocyte Anatomy 0.000 description 1
• 230000000925 erythroid effect Effects 0.000 description 1
• 201000011384 erythromelalgia Diseases 0.000 description 1
• 230000000913 erythropoietic effect Effects 0.000 description 1
• 229940105423 erythropoietin Drugs 0.000 description 1
• 125000004185 ester group Chemical group 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 201000005884 exanthem Diseases 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 208000030533 eye disease Diseases 0.000 description 1
• 208000024519 eye neoplasm Diseases 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 230000004720 fertilization Effects 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 208000008487 fibromuscular dysplasia Diseases 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 230000022244 formylation Effects 0.000 description 1
• 238000006170 formylation reaction Methods 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000007429 general method Methods 0.000 description 1
• 238000010353 genetic engineering Methods 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 210000000585 glomerular basement membrane Anatomy 0.000 description 1
• 150000002303 glucose derivatives Polymers 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 150000002304 glucoses Polymers 0.000 description 1
• 125000002791 glucosyl group Polymers C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 210000002288 golgi apparatus Anatomy 0.000 description 1
• 239000011544 gradient gel Substances 0.000 description 1
• 238000005469 granulation Methods 0.000 description 1
• 230000003179 granulation Effects 0.000 description 1
• 210000004884 grey matter Anatomy 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 208000019622 heart disease Diseases 0.000 description 1
• 208000024348 heart neoplasm Diseases 0.000 description 1
• 208000025339 heart septal defect Diseases 0.000 description 1
• 208000025750 heavy chain disease Diseases 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 201000002222 hemangioblastoma Diseases 0.000 description 1
• 201000011066 hemangioma Diseases 0.000 description 1
• 208000014951 hematologic disease Diseases 0.000 description 1
• 208000014617 hemorrhoid Diseases 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 208000018645 hepatic veno-occlusive disease Diseases 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 238000012188 high-throughput screening assay Methods 0.000 description 1
• 231100000171 higher toxicity Toxicity 0.000 description 1
• 108010044853 histidine-rich proteins Proteins 0.000 description 1
• 229940098197 human immunoglobulin g Drugs 0.000 description 1
• 208000021145 human papilloma virus infection Diseases 0.000 description 1
• 210000004408 hybridoma Anatomy 0.000 description 1
• 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 238000012872 hydroxylapatite chromatography Methods 0.000 description 1
• 201000006362 hypersensitivity vasculitis Diseases 0.000 description 1
• 230000036543 hypotension Effects 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 230000002989 hypothyroidism Effects 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 239000012642 immune effector Substances 0.000 description 1
• 201000008269 immune-complex glomerulonephritis Diseases 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 230000005847 immunogenicity Effects 0.000 description 1
• 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 208000025095 immunoproliferative disease Diseases 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 238000011503 in vivo imaging Methods 0.000 description 1
• 238000010249 in-situ analysis Methods 0.000 description 1
• 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 210000005007 innate immune system Anatomy 0.000 description 1
• 102000028416 insulin-like growth factor binding Human genes 0.000 description 1
• 108091022911 insulin-like growth factor binding Proteins 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 229940117681 interleukin-12 Drugs 0.000 description 1
• 229940076264 interleukin-3 Drugs 0.000 description 1
• 229940100602 interleukin-5 Drugs 0.000 description 1
• 229940118526 interleukin-9 Drugs 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 208000021156 intermittent vascular claudication Diseases 0.000 description 1
• 201000002313 intestinal cancer Diseases 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 238000007917 intracranial administration Methods 0.000 description 1
• 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 238000007914 intraventricular administration Methods 0.000 description 1
• 229940029329 intrinsic factor Drugs 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 208000037906 ischaemic injury Diseases 0.000 description 1
• 201000008222 ischemic colitis Diseases 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 239000007951 isotonicity adjuster Substances 0.000 description 1
• 230000000155 isotopic effect Effects 0.000 description 1
• 210000005067 joint tissue Anatomy 0.000 description 1
• 201000004990 juvenile ankylosing spondylitis Diseases 0.000 description 1
• 230000000366 juvenile effect Effects 0.000 description 1
• 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 108010000761 leucylarginine Proteins 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 201000002364 leukopenia Diseases 0.000 description 1
• 231100001022 leukopenia Toxicity 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 108010075796 liver regeneration factor 1 Proteins 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 208000004731 long QT syndrome Diseases 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 206010025135 lupus erythematosus Diseases 0.000 description 1
• 210000002751 lymph Anatomy 0.000 description 1
• 208000037829 lymphangioendotheliosarcoma Diseases 0.000 description 1
• 208000012804 lymphangiosarcoma Diseases 0.000 description 1
• 231100001023 lymphopenia Toxicity 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 201000000564 macroglobulinemia Diseases 0.000 description 1
• 208000002780 macular degeneration Diseases 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 230000001071 malnutrition Effects 0.000 description 1
• 235000000824 malnutrition Nutrition 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 108010057546 matrix Gla protein Proteins 0.000 description 1
• 102000043253 matrix Gla protein Human genes 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 210000001767 medulla oblongata Anatomy 0.000 description 1
• 208000023356 medullary thyroid gland carcinoma Diseases 0.000 description 1
• 230000005499 meniscus Effects 0.000 description 1
• 201000008287 mesenteric vascular occlusion Diseases 0.000 description 1
• 208000030159 metabolic disease Diseases 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 230000001394 metastastic effect Effects 0.000 description 1
• 206010061289 metastatic neoplasm Diseases 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 210000001589 microsome Anatomy 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 208000005907 mitral valve insufficiency Diseases 0.000 description 1
• 208000006887 mitral valve stenosis Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 230000004001 molecular interaction Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 201000006894 monocytic leukemia Diseases 0.000 description 1
• 210000002864 mononuclear phagocyte Anatomy 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• 210000003887 myelocyte Anatomy 0.000 description 1
• 208000025113 myeloid leukemia Diseases 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 208000002089 myocardial stunning Diseases 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• 208000001611 myxosarcoma Diseases 0.000 description 1
• 230000006654 negative regulation of apoptotic process Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 208000025189 neoplasm of testis Diseases 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 201000003142 neovascular glaucoma Diseases 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 239000003900 neurotrophic factor Substances 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 208000004235 neutropenia Diseases 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 239000002853 nucleic acid probe Substances 0.000 description 1
• 208000015380 nutritional deficiency disease Diseases 0.000 description 1
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 230000001599 osteoclastic effect Effects 0.000 description 1
• 230000002018 overexpression Effects 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 230000004783 oxidative metabolism Effects 0.000 description 1
• 239000003002 pH adjusting agent Substances 0.000 description 1
• 239000006179 pH buffering agent Substances 0.000 description 1
• 230000000242 pagocytic effect Effects 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 201000010198 papillary carcinoma Diseases 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 210000003681 parotid gland Anatomy 0.000 description 1
• 208000008510 paroxysmal tachycardia Diseases 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 208000003278 patent ductus arteriosus Diseases 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 208000030613 peripheral artery disease Diseases 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 201000005936 periventricular leukomalacia Diseases 0.000 description 1
• 102000013415 peroxidase activity proteins Human genes 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• 208000001297 phlebitis Diseases 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 229940080469 phosphocellulose Drugs 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 238000005222 photoaffinity labeling Methods 0.000 description 1
• 230000036211 photosensitivity Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 208000024724 pineal body neoplasm Diseases 0.000 description 1
• 201000004123 pineal gland cancer Diseases 0.000 description 1
• 210000003635 pituitary gland Anatomy 0.000 description 1
• 238000013492 plasmid preparation Methods 0.000 description 1
• 208000008423 pleurisy Diseases 0.000 description 1
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
• 201000006292 polyarteritis nodosa Diseases 0.000 description 1
• 208000037244 polycythemia vera Diseases 0.000 description 1
• 229920000573 polyethylene Polymers 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 238000012809 post-inoculation Methods 0.000 description 1
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 239000001294 propane Substances 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 102000021127 protein binding proteins Human genes 0.000 description 1
• 108091011138 protein binding proteins Proteins 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 201000010298 pulmonary valve insufficiency Diseases 0.000 description 1
• 208000009138 pulmonary valve stenosis Diseases 0.000 description 1
• 150000003212 purines Chemical class 0.000 description 1
• 150000003230 pyrimidines Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 229920005604 random copolymer Polymers 0.000 description 1
• 206010037844 rash Diseases 0.000 description 1
• 208000002574 reactive arthritis Diseases 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000020404 regulation of osteoclast differentiation Effects 0.000 description 1
• 208000009169 relapsing polychondritis Diseases 0.000 description 1
• 210000005227 renal system Anatomy 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 210000001995 reticulocyte Anatomy 0.000 description 1
• 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 229960004641 rituximab Drugs 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 231100000241 scar Toxicity 0.000 description 1
• 230000037387 scars Effects 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 201000008407 sebaceous adenocarcinoma Diseases 0.000 description 1
• 239000006152 selective media Substances 0.000 description 1
• 210000000582 semen Anatomy 0.000 description 1
• 210000001625 seminal vesicle Anatomy 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000001235 sensitizing effect Effects 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• WGWPRVFKDLAUQJ-MITYVQBRSA-N sermorelin Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O)C1=CC=C(O)C=C1 WGWPRVFKDLAUQJ-MITYVQBRSA-N 0.000 description 1
• 229960002758 sermorelin Drugs 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 239000002924 silencing RNA Substances 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 210000004927 skin cell Anatomy 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 239000001509 sodium citrate Substances 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 230000007928 solubilization Effects 0.000 description 1
• 238000005063 solubilization Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 206010041823 squamous cell carcinoma Diseases 0.000 description 1
• 230000010473 stable expression Effects 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 239000000021 stimulant Substances 0.000 description 1
• 229960005202 streptokinase Drugs 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 238000012916 structural analysis Methods 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 206010042431 subvalvular aortic stenosis Diseases 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000003457 sulfones Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 208000010648 susceptibility to HIV infection Diseases 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 201000010965 sweat gland carcinoma Diseases 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 206010042863 synovial sarcoma Diseases 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 210000001138 tear Anatomy 0.000 description 1
• 208000009056 telangiectasis Diseases 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 229940126622 therapeutic monoclonal antibody Drugs 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 201000005060 thrombophlebitis Diseases 0.000 description 1
• 210000001685 thyroid gland Anatomy 0.000 description 1
• 206010043778 thyroiditis Diseases 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 206010044325 trachoma Diseases 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 108091008578 transmembrane receptors Proteins 0.000 description 1
• 208000014903 transposition of the great arteries Diseases 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 201000011112 tricuspid valve prolapse Diseases 0.000 description 1
• ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
• 229940038773 trisodium citrate Drugs 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 239000012588 trypsin Substances 0.000 description 1
• 229960001322 trypsin Drugs 0.000 description 1
• 230000004565 tumor cell growth Effects 0.000 description 1
• ZHSGGJXRNHWHRS-VIDYELAYSA-N tunicamycin Chemical compound O([C@H]1[C@@H]([C@H]([C@@H](O)[C@@H](CC(O)[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(NC(=O)C=C2)=O)O)O1)O)NC(=O)/C=C/CC(C)C)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1NC(C)=O ZHSGGJXRNHWHRS-VIDYELAYSA-N 0.000 description 1
• MEYZYGMYMLNUHJ-UHFFFAOYSA-N tunicamycin Natural products CC(C)CCCCCCCCCC=CC(=O)NC1C(O)C(O)C(CC(O)C2OC(C(O)C2O)N3C=CC(=O)NC3=O)OC1OC4OC(CO)C(O)C(O)C4NC(=O)C MEYZYGMYMLNUHJ-UHFFFAOYSA-N 0.000 description 1
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
• 230000034512 ubiquitination Effects 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 201000004822 varicocele Diseases 0.000 description 1
• 208000027185 varicose disease Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 208000019553 vascular disease Diseases 0.000 description 1
• 230000003156 vasculitic effect Effects 0.000 description 1
• 235000013311 vegetables Nutrition 0.000 description 1
• 201000002282 venous insufficiency Diseases 0.000 description 1
• 230000006815 ventricular dysfunction Effects 0.000 description 1
• 208000003663 ventricular fibrillation Diseases 0.000 description 1
• 201000003130 ventricular septal defect Diseases 0.000 description 1
• 206010047302 ventricular tachycardia Diseases 0.000 description 1
• 201000010653 vesiculitis Diseases 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 208000006542 von Hippel-Lindau disease Diseases 0.000 description 1
• 208000035603 warm type autoimmune hemolytic anemia Diseases 0.000 description 1
• 238000005406 washing Methods 0.000 description 1
• 208000016261 weight loss Diseases 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 210000004885 white matter Anatomy 0.000 description 1
• 235000021241 α-lactalbumin Nutrition 0.000 description 1
• 235000021247 β-casein Nutrition 0.000 description 1
• 235000021246 κ-casein Nutrition 0.000 description 1